Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Poland / NCT07748416
Starting soon Not applicable

The Effects of Acute Nitrate and Caffeine Co-ingestion on Discipline-Specific Exercise Performance.

NCT07748416 · tracked via the Priya Life Science Poland tracker
Phase
Not applicable
Started
2026-10-01
Last updated
2026-08-07

Condition(s) studied

Athletic PerformanceDietary SupplementIron Status

Investigational drug(s) / intervention(s)

CaffeineDietary Nitrate (Beetroot Juice)Placebo (Maltodextrin Capsule)Placebo (Nitrate-Depleted Beetroot Juice)

Caffeine: Anhydrous caffeine administered orally in a hard gelatine capsule. To address the unique physiological profiles of the two cohorts, a highly specific, differentiated dosing protocol is implemented: Cohort A (adult functional fitness athletes) will receive a high-performance dose of 6 mg/kg body mass, while Cohort B (elite junior swimmers) will receive a safe, youth-adapted dose of 3 mg/kg body mass. In all experimental trials, the capsule is ingested exactly 60 minutes prior to the onset of the discipline-specific exercise test to match peak plasma caffeine concentration.

Dietary Nitrate (Beetroot Juice): Concentrated beetroot juice (BJ) administered as a single, acute organic shot of 70 mL (Beet It Sport, James White Drinks Ltd., Ipswich, UK). Each active shot contains approximately 400 mg (equivalent to \~6.4 mmol) of inorganic nitrate. In contrast to chronic loading designs, this study evaluates purely acute effects; the shot is ingested exactly 3 hours (180 minutes) prior to the physical performance test to align with peak systemic concentration of plasma nitrite.

Placebo (Maltodextrin Capsule): Placebo capsule containing inert maltodextrin powder. The capsule is identical in size, shape, weight, color (opaque), and texture to the active caffeine capsule to ensure robust blinding. It is administered at the exact same time point (60 minutes pre-exercise) according to the identical body-mass-adjusted dosing scheme (simulating either 3 mg/kg or 6 mg/kg).

Placebo (Nitrate-Depleted Beetroot Juice): Nitrate-depleted beetroot juice (Beet It, James White Drinks Ltd., Ipswich, UK) administered as a 70 mL shot. This placebo is identical in taste, smell, appearance, packaging, and viscosity to the active concentrated shot, but has been selectively filtered to contain negligible nitrate levels (\<0.4 mmol / \~25 mg of nitrates). It is ingested exactly 3 hours prior to the exercise test.

Study summary

The purpose of this study is to investigate the acute, separate, and combined ergogenic effects of dietary nitrate (beetroot juice, BJ) and caffeine (CAF) supplementation on discipline-specific athletic performance. The project employs a double-blind, randomized, placebo-controlled, four-arm crossover design. It evaluates two highly distinct, heterogeneous populations of athletes: (A) adult high-intensity functional training (HIFT/CrossFit/Hyrox) competitors performing the standardized Hyrox Physical Fitness Test (P'F'T), and (B) elite junior competitive swimmers (National Team members) performing a progressive 8 × 100 m swimming test. The study will assess physical performance, lactate kinetics, subjective exertion, biochemical indices, psychological metrics, and gastrointestinal tolerance.

Eligibility

Sex
ALL
Min age
16 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: A) Cohort A (HIFT / CrossFit / Hyrox): * Aged 18-45 years. * Minimum of 2 years of systematic HIFT/CrossFit/Hyrox training experience. * Performing \>4 training sessions per week. * Ability to perform the HYROX Physical Fitness Test (P'F'T) and has participated in at least one official HYROX event. * Possession of a valid medical certificate proving eligibility for competitive sports. B) Cohort B (Competitive Junior Swimmers): * Aged 16-19 years. * Active member of the Polish Junior National Swimming Team. * Minimum of 5 years of competitive swimming experience. * Current training volume of at least 8-10 pool training sessions per week. * Written informed consent obtained from both the participant and their legal guardian (for minors under 18). C)Common Criteria for Both Cohorts: * No history of cardiovascular, respiratory, metabolic, or musculoskeletal disease contradicting high-intensity exercise or stimulant intake. * No known food allergies or adverse reactions to beetroot products or caffeine. * No current use of medications that alter nitrate/caffeine metabolism (e.g., proton pump inhibitors, antibiotics, phosphodiesterase inhibitors). * History of uneventful habituation to caffeine use during training/competition. * Willingness to abstain from dietary supplements, antibacterial mouthwashes, alcohol, and high-nitrate foods for 48 hours prior to each testing session. * Good general health and physical well-being. Exclusion Criteria (Applicable to both cohorts): * Occurrence of acute musculoskeletal injury or trauma during the study period. * Any medical or health contraindications (including severe menstrual disorders, planned pregnancy, or breastfeeding). * Failure or refusal to strictly adhere to the dietary, supplementation, and exercise testing protocols.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Poznan University of Physical Education Poznan Wielkopolska

More Poznan University of Physical Education trials in Poland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07748416 on ClinicalTrials.gov ↗ ← All trials in Poland